Portland, OR, United States of America

Harvey L Claussen

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Harvey L Claussen: Innovator in Dimethyl Sulfoxide Administration

Introduction

Harvey L Claussen is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of pharmaceuticals, particularly in the administration of dimethyl sulfoxide (DMSO) and related compounds. With a total of 4 patents, Claussen's work has paved the way for advancements in safe and effective drug delivery systems.

Latest Patents

Claussen's latest patents include innovative materials designed to facilitate the administration of DMSO. One of his inventions comprises a kit that includes items used for the safe and effective administration of DMSO. Another significant patent focuses on devices for the removal of DMSO or related compounds, as well as associated odors. These devices incorporate various elements such as adsorbents, odor-adsorbing fabrics, and clean air supply assemblies, showcasing Claussen's commitment to improving user experience and safety.

Career Highlights

Throughout his career, Claussen has worked with several companies, including Abela Pharmaceuticals, Inc. and R Value, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and product development.

Collaborations

Claussen has collaborated with notable individuals in his field, including Colette Cozean and Jack De La Torre. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Harvey L Claussen's contributions to the field of pharmaceuticals, particularly in the administration of DMSO, highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to safety and effectiveness in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…